Bayer profits hit by $500M charge for Yaz/Yasmin lawsuits

Bayer set aside $500 million to cover litigation over the Yaz and Yasmin birth control pills, after FDA added blood-clot warnings to their labels in April. Meanwhile, the company's second-quarter numbers benefited from strong emerging markets sales. Report